Literature DB >> 20619708

Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function.

Vincenza Spallone1, Roberto Morganti, Cinzia D'Amato, Laura Cacciotti, Tiziana Fedele, Maria R Maiello, Girolama Marfia.   

Abstract

BACKGROUND: This study investigated the clinical correlates of painful diabetic polyneuropathy (PDPN) and the relationship of neuropathic pain with sensorimotor and autonomic nerve function.
METHODS: Seventy-eight diabetic patients with PDPN (PDPN(+)), 57 with non-painful diabetic polyneuropathy (DPN(+)), and 56 without diabetic polyneuropathy (DPN(-)) were prospectively studied. Autonomic neuropathy, neuropathic symptoms and signs, vibration perception threshold, and neuropathic pain were assessed using 4 cardiovascular tests, scoring systems for symptoms and signs (Michigan Diabetic Neuropathy Score, MDNS), Biothesiometer, and a numerical rating scale.
RESULTS: Compared to DPN(+), PDPN(+) patients displayed higher BMI (P=0.0043), waist circumference (P=0.0057), neuropathy symptom score (P<0.0001), MDNS (P<0.0001), and lower Valsalva ratio (P=0.037). In a multiple logistic regression analysis including PDPN as the dependent variable and age, sex, body mass index (BMI), abdominal obesity, diabetes type, diabetes duration, HbA1c, blood pressure, triglycerides, smoking, peripheral arterial disease, Valsalva ratio and MDNS as the independent variables, BMI (OR 1.22, P=0.0012) and MDNS (OR 1.27, P=0.0005) were significantly and independently associated with PDPN. In a multivariate regression analysis including as independent variables also sex, age, diabetes type, diabetes duration and Valsalva ratio, 24-h pain score was significantly related to neuropathy symptom score (P=0.0011), MDNS (P=0.0158), and 10g monofilament (P=0.018). DISCUSSION: BMI and sensorimotor deficits were the main determinants of PDPN and, as a novel finding, neuropathic pain intensity was related to the degree of neuropathy deficits. Thus, some peculiarity exists in metabolic correlates of diabetic neuropathic pain compared to insensate neuropathy but painfulness can still coexist with insensitivity.
Copyright © 2010 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20619708     DOI: 10.1016/j.ejpain.2010.06.011

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  18 in total

1.  Electrophysiologic pattern and prevalence of subclinical peripheral neuropathy in children and adolescents with type I diabetes mellitus in Iran.

Authors:  Vahideh Toopchizadeh; Siamak Shiva; Nader-Yousefzadeh Khiabani; Robabeh Ghergherechi
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

2.  Chemotherapy-Induced Neuropathy in Cancer Survivors.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Kimberly Topp; Betty Smoot; Gary Abrams; Lee-May Chen; Kord M Kober; Yvette P Conley; Margaret Chesney; Kay Bolla; Grace Mausisa; Melissa Mazor; Melisa Wong; Mark Schumacher; Jon D Levine
Journal:  J Pain Symptom Manage       Date:  2017-01-04       Impact factor: 3.612

Review 3.  The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Carole Clair; Marya J Cohen; Florian Eichler; Kevin J Selby; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2015-05-07       Impact factor: 5.128

Review 4.  Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.

Authors:  Gordon Sloan; Dinesh Selvarajah; Solomon Tesfaye
Journal:  Nat Rev Endocrinol       Date:  2021-05-28       Impact factor: 43.330

Review 5.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

6.  Self-care of patients with type 2 diabetes mellitus over the course of illness: implications for tailoring support.

Authors:  Marise Kasteleyn; Lianne de Vries; Anne van Puffelen; Mieke Rijken; Monique Heijmans; Giel Nijpels; François Schellevis
Journal:  J Diabetes Metab Disord       Date:  2020-01-27

7.  Profile of microvascular disease in type 2 diabetes in a tertiary health care hospital in India.

Authors:  Hari Kvs Kumar; Sk Kota; A Basile; Kd Modi
Journal:  Ann Med Health Sci Res       Date:  2012-07

8.  Associations of metabolic factors and adipokines with pain in incipient upper extremity soft tissue disorders: a cross-sectional study.

Authors:  Martti Rechardt; Rahman Shiri; Harri Lindholm; Jaro Karppinen; Eira Viikari-Juntura
Journal:  BMJ Open       Date:  2013-08-19       Impact factor: 2.692

9.  Effect of glycemic control on sudomotor denervation in type 2 diabetes.

Authors:  Kai-Ren Luo; Chi-Chao Chao; Paul-Chen Hsieh; June-Horng Lue; Sung-Tsang Hsieh
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

10.  Corneal nerve loss is related to the severity of painful diabetic neuropathy.

Authors:  Alise Kalteniece; Maryam Ferdousi; Shazli Azmi; Saif Ullah Khan; Anne Worthington; Andrew Marshall; Catharina G Faber; Giuseppe Lauria; Andrew J M Boulton; Handrean Soran; Rayaz A Malik
Journal:  Eur J Neurol       Date:  2021-10-13       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.